Companies / Pennsylvania / Xenagos Bio

· rebuilt nightly from public records

Signal Sheet

Selling to Xenagos Bio? Who to reach and why now

Xenagos Bio is a private biotechnology company in Philadelphia, Pennsylvania, founded 2025. It raised $2.5M in Apr 2026 and its filings name 3 officers. Everything below links to the record it came from.

Private company · Biotechnology · Pennsylvania

The easy button for new customers

Lakewave's AI keeps accounts like this one coming. Your pipeline refills while you sleep.

Every night it scans funding, filings, new officers, hiring, contracts, permits and bids, finds the accounts that fit what you sell, and delivers each with outreach and a pursuit plan. Just need a list? Its AI waterfall builds one with verified, reachable contacts.

SourceNew accounts that match what you offer, added as the signals land. The list never runs dry.
Reach outA first email written from why the account is hot, then a drip sequence that follows up until they reply. Sent from your own mailbox, with every open and reply tracked.
PursueAn AI-written plan built from your value proposition and the customer's compelling event: who to call, what to lead with, and the next step to win it. In early access.
Start your free trial →Tell it what you sell and where. Your list stays yours.

Who to reach

The roles that matter for a seller right now. Names on this page come from SEC filings or the company's own announcements. Contacts you find with a free trial are verified before you see them. How we source names

RoleContactSourceWhy they matter now
Executive OfficerMichael J. McElhaughSEC filing, Apr 2026Named officer in the filing; part of the buying group
Chief Technology OfficerAbel De La RosaSEC filing, Apr 2026Technology and tooling decisions
Chief Technology OfficerPatrick HigginsSEC filing, Apr 2026Technology and tooling decisions
Chief Executive OfficerFind with a free trialLakewave contact searchSigns off on new vendors; budget owner
Chief Financial OfficerFind with a free trialLakewave contact searchApproves spend after a raise
Chief Information OfficerFind with a free trialLakewave contact searchOwns IT and infrastructure vendors
For sellersWhy Xenagos Bio is worth a call this quarterBuy Window: watching
$2.5M

Raised

Equity raise reported to the SEC, Apr 2026. Money arrives before the spending plan does.

Capital
3officers

Named in filings

Each with a title and the filing that names them, so the first call goes to the right desk.

People
Track Xenagos Bio with a free trial →Get the next signal the day it is filed or posted.
Email me the next Xenagos Bio signalOne email when it files, raises, hires or posts a role. Watch up to 3 companies free, no password.

Why now

The most recent events first, refreshed every night. Each links to the record it came from.

WhenWhat happenedKindSource
Apr 30, 2026Raised $2.5M in equity from 23 investorsCapitalSEC filing

Email format

Xenagos Bio uses [email protected]. For someone named Jane Doe that is [email protected]. Lakewave confirmed this pattern. A company pattern is the common shape, not a guarantee for any one person. Many companies run more than one format at once: founders, early hires, acquired teams and regional offices often differ. So Lakewave does not apply one pattern across a whole company. It verifies the address for each person on its own, and a free trial gives you the email that reaches each person above.
Get verified addresses, free →

Reach Xenagos Bio with emails that land

Lakewave finds the right people at Xenagos Bio, checks every address against the mail server before you see it, and drafts a first email for each, which you review and send from your own inbox.

Try it on Xenagos Bio with a free trial →

About Xenagos Bio

HeadquartersPhiladelphia, Pennsylvania, per the filing address
Industry groupBiotechnology
Founded2025, DELAWARE
OwnershipPrivate company
Raise history$2.5M (Apr 2026)
Lakewave Rising5 · 1 kinds of evidence · rank in Pennsylvania after sign-up

Similar companies

Private-sector companies in the same industry group and state, ranked by Rising score.

Tolerance Bio · 9Myris Therapeutics · 8See all 2 with a free trial →

Questions people ask

Did Xenagos Bio raise funding in 2026?

Yes. Xenagos Bio reported a $2.5M equity raise to the SEC on Apr 30, 2026 with 23 investors.

Who runs Xenagos Bio?

The company's SEC filing, Apr 2026 names Michael J. McElhaugh (Executive Officer) among its officers.

Where is Xenagos Bio headquartered?

Philadelphia, Pennsylvania, per the address on its SEC filing.

What is Xenagos Bio's email format?

Xenagos Bio uses [email protected]. For someone named Jane Doe that is [email protected]. Lakewave confirmed this pattern.

Does everyone at Xenagos Bio use the same email format?

Not always. Many companies run more than one format at once: founders, early hires, acquired teams and regional offices often differ. That is why Lakewave does not apply one pattern across a whole company. It verifies the address for each person on its own, so you are not relying on a guessed pattern.

Know who is buying before the first callStart your free trial →

Know who is buying before the first call

Select the accounts and territory you sell to and get dated reasons for every company: new budget, new leaders, new hires, with who to reach and a first draft for each contact.

Start your free trial

Compiled from public records and refreshed nightly; last updated Nov 16, 2026. Facts are as the SEC, the company's careers page or the company's own announcements published them. Check the source before acting. See something wrong? Tell us and we will correct it.